A significant reduction in plasma omentin concentration was observed in patients with T2DM complicated by microcirculation damage conditions, such as diabetic retinopathy (DR), diabetic neuropathy, and diabetic nephropathy [37]. This evidence concerns the gene ITLN1 and type 2 diabetes mellitus.